The vast majority of mammalian DNA does not encode for proteins but instead is transcribed into noncoding (nc)RNAs having diverse regulatory functions. The poorly characterized subclass of long ncRNAs (lncRNAs) can epigenetically regulate protein-coding genes by interacting locally in cis or distally in trans. A few reports have implicated specific lncRNAs in cardiac development or failure, but precise details of lncRNAs expressed in hearts and how their expression may be altered during embryonic heart development or by adult heart disease is unknown. Using comprehensive quantitative RNA sequencing data from mouse hearts, livers, and skin cells, we identified 321 lncRNAs present in the heart, 117 of which exhibit a cardiac-enriched pattern of expression. By comparing lncRNA profiles of normal embryonic (∼E14), normal adult, and hypertrophied adult hearts, we defined a distinct fetal lncRNA abundance signature that includes 157 lncRNAs differentially expressed compared with adults (fold-change ≥ 50%, false discovery rate = 0.02) and that was only poorly recapitulated in hypertrophied hearts (17 differentially expressed lncRNAs; 13 of these observed in embryonic hearts). Analysis of protein-coding mRNAs from the same samples identified 22 concordantly and 11 reciprocally regulated mRNAs within 10 kb of dynamically expressed lncRNAs, and reciprocal relationships of lncRNA and mRNA levels were validated for the Mccc1 and Relb genes using in vitro lncRNA knockdown in C2C12 cells. Network analysis suggested a central role for lncRNAs in modulating NFκB-and CREB1-regulated genes during embryonic heart growth and identified multiple mRNAs within these pathways that are also regulated, but independently of lncRNAs.
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fetal heart | pressure overload O ne of the revelations from sequencing whole genomes and the Encyclopedia of DNA Elements project is the small proportion of the mammalian genome dedicated to proteincoding genes. The majority of genomic DNA encode regulatory noncoding (nc)RNAs, i.e., transcripts that instead of simply acting as templates for protein translation exert their own intrinsic functions. MicroRNAs are the best-studied subclass of ncRNAs, being dynamically regulated small (∼20 nt) single-stranded RNAs that, in the heart, are recognized as central orchestrators of cardiac development and stress adaptation. MicroRNAs control entire biological pathways by targeting multiple mRNAs involved in cell growth, differentiation, and apoptosis by suppressing the translation of central protein effectors (1) . By contrast, long ncRNAs (lncRNAs) of 200-2,000 nt or larger are distinguished by a diversity of molecular functioning derived from their ability to fold into complex structures and act as scaffolds for protein-protein interactions and/or chaperones that direct protein complexes to specific RNA or DNA sequences (2) . Important roles for some lncRNAs are emerging in heart development (3, 4) and have been suggested in experimental and human heart failure (5, 6). However, interpretation and broader application of these early findings is constrained by uncertainty as to how lncRNAs are regulated in different cardiac developmental and disease states and whether regulated lncRNAs differ between these states. Indeed, it is not yet known with certainty which lncRNAs are expressed in mouse hearts, nor have the identities of lncRNAs exhibiting "cardiacenriched" expression been defined. To address this deficit, we applied comprehensive next-generation sequencing and advanced computational approaches to identify cardiac-expressed and cardiac-specific lncRNAs, defining cardiac lncRNA expression signatures of late embryonic, normal adult, and hemodynamically stressed adult hearts. Building on this foundation, we used bioinformatic analysis to integrate expression profiles and genomic locations of dynamically regulated lncRNAs and mRNAs, identifying and biologically validating cardiac mRNAs whose expression in the developing embryonic heart appears to be directed in part by regulated lncRNAs.
Results
Delineation of Cardiac-Expressed and Cardiac-Enriched lncRNAs. As a first step to defining mouse cardiac lncRNAs, we interrogated archived raw deep RNA sequencing data from n = 25 normal adult FVB/N mouse hearts (age, 8-16 wk) (7-11) and compared these results to RNA sequencing data from n = 7 mouse livers and n = 6 independent cultures of primary mouse keratinocytes (skin cells). Noncode v3.0 lists ∼37,000 potential lncRNAs in the mouse genome, but these predictions are based largely on unvalidated FANTOM3 cDNAs (12) . Therefore, we developed a curated list
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This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. 1073/pnas.1410622111/-/DCSupplemental. of 2,997 mouse lncRNAs by combining the annotated lncRNAs from Noncode 2.0, lncRNAdb, Scripture, fRNAdb, Ensembl, RefSeq, and the UCSC Genome database, but eliminated sequences that overlapped with known mRNA exons, leaving 2,140 mouse lncRNAs (SI Methods and Dataset S1). Of these, we detected 736 lncRNAs (∼33% of the annotated list) in at least half of any of the three tissue samples (Dataset S2); lncRNAs comprised 0.3-0.7% of the sequencing reads mapped to transcribed RNAs, which include all defined mRNAs together with the 2,140 defined lncRNAs. Both principal components analysis (Fig. 1A ) and unsupervised hierarchical clustering of individual lncRNA sequence read abundance ( Fig. 1B and Fig. S1 ) revealed tissuespecific lncRNA expression profiles, consistent with previous observations that lncRNAs exhibit greater tissue specificity in expression profile than mRNAs (13) . A total of 546 lncRNAs were detected in the adult heart samples at levels ranging from 210 RPKM (reads per kilobase of sequence per million reads mapping to transcribed RNAs) for the most abundant lncRNA, n415312, to 0.006 RPKM for lncRNA n411743, one of the longer lncRNAs present at the specified threshold of detection based on sequencing read counts (SI Methods). Approximately 200 lncRNAs detected in hearts were present at very low levels (<0.3 RPKM), likely to be of lesser biological significance ( Fig. S1 and Dataset S2). Based on these results and additional RNA sequencing of late embryonic and pressure overloaded hearts (vide infra), we designated 321 lncRNAs as cardiac expressed, i.e., having a mean RPKM of >0.3 in at least one cardiac subgroup (normal embryo, normal adult, adult sham-operated, or pressure overloaded). Of the 321 cardiac-expressed lncRNAs (>0.3 RPKM), 117 were enriched at least threefold in adult hearts compared with liver and skin ( Fig. 1 B and C) , including the requisite cardiac lncRNA Braveheart (n267831; 16.4 RPKM in adult hearts) (3) .
A total of 152 cardiac lncRNAs were expressed at levels >1 RPKM in normal adult hearts and were designated as abundant cardiac lncRNAs; these comprised at least 90% of the total cardiac lncRNA sequencing reads ( Fig. S1 and Dataset S2). Forty-eight of these abundant cardiac lncRNAs, including Braveheart (vide supra), were defined as cardiac enriched. In total, our studies in normal adult mouse hearts identified 48 abundant cardiacenriched lncRNAs and 104 abundant lncRNAs that are more generally expressed in liver and/or skin, as well as hearts. To determine the cellular fraction(s) to which these abundant cardiac lncRNAs belong, we subjected adult mouse hearts to collagenase digestion (SI Methods) and performed RNA sequencing assays on cardiomyocytes and fibroblasts (Dataset S3). Of the 48 abundant, cardiac-enriched lncRNAs, 32 (67%) were enriched at least threefold in the cardiomyocyte fraction of the heart, whereas only 2 (4.2%) were enriched in the fibroblast fraction (Dataset S3).
Differences in mouse strain can be a source of genetic and transcriptional variation and a confounding factor when comparing experimental results from two or more research groups. We compared lncRNA expression detected by RNA-sequencing on 25 FVB/ N hearts and 16 C57BL/6 hearts, two lines with known biological distinctiveness (14) (15) (16) (17) . Similar lncRNA expression signatures were observed for 546 detectable lncRNAs in these adult mouse hearts (Fig. S2 A and B) with only a few statistically significant differences, most of which involved lncRNAs present at relatively low levels ( Hearts. Cardiac-specific patterns of expression for some lncRNAs suggest that they may play a role in heart development. Indeed, the cardiac-enriched lncRNA Braveheart/n267831 reportedly plays a central regulatory role in cardiomyocyte differentiation (3) . We determined what other cardiac lncRNAs are differentially expressed in developing embryonic hearts at ∼E13.5 (range, E13-E14.5), a stage when progenitor cell commitment/differentiation is largely complete and myocardial growth through cardiomyocyte proliferation is active. Because we were interested in identifying those lncRNAs with possible roles in cardiac development, we focused our analyses on lncRNAs present at >0.3 RPKM.
Unsupervised clustering of the raw expression (RPM) values of 321 cardiac-expressed lncRNAs perfectly segregated embryonic from adult hearts ( Fig. 2A) , identifying a distinct lncRNA signature for developing hearts. A total of 157 lncRNAs (approximately half of cardiac-expressed lncRNAs) exhibited significant differences [false discovery rate (FDR) = 0.02, >50% increase or decrease] in expression between embryonic and adult mouse hearts (Fig. 2 B and C (18) .
lncRNA and mRNA Regulation in Early and Late Cardiac Pressure Overload. We asked if adult cardiac disease induced fetal-like changes in the lncRNA expression signature. RNA sequencing was performed on four pairs of sham-operated hearts and hearts of mice 1 and 4 wk after induction of acute pressure overload by microsurgical subtotal ligation of the transverse aorta [transverse aortic coarctation (TAC)], which evokes changes in cardiac mRNA and microRNA expression also seen in clinical heart failure (8) . In accordance with our previous studies (8, 19) , we observed hypertrophy without severe deterioration of cardiac function at both of these time points (Fig. S3) . Eleven lncRNAs were significantly regulated 1 wk after TAC (Fig. 2 D-F) , with similar trends after 4 wk (Fig. 2 D-F and Dataset S6).
Compared with sham-operated controls, only 17 cardiacexpressed lncRNAs were expressed at different levels after 1 or 4 wk of TAC (Fig. 3A and Dataset S6), despite the usual alterations in fetal gene mRNAs (Fig. 3B) . Thirteen of these 17 lncRNAs also showed differences in expression between embryonic and adult hearts. Thus, dynamic expression of lncRNAs was more prominent in cardiac growth when transitioning from embryo to adult (157 lncRNAs) than in the hypertrophic response to increased hemodynamic stress (17 lncRNAs). Comparison of the expression signatures for 321 cardiac-expressed lncRNAs (regardless of statistical categorization) across normal E14.5 embryonic, normal adult, sham operated adult, and pressure overloaded adult (TAC) hearts supports the conclusion that lncRNA expression markedly differs between fetal and adult hearts but is similar in healthy and hypertrophied adult hearts (Fig. 3 C and D  and Fig. S4) .
Because lncRNAs exert their effects in part via epigenetic regulation of gene expression (2), we asked what mRNA changes occur concomitantly with changes in lncRNA levels. As expected, mRNA sequencing (10) of the same hearts revealed distinct mRNA signatures for embryonic, adult, and hemodynamically stressed hearts ( Fig. 3 E and F, Fig. S4 , and Dataset S7). Partial overlap of regulated lncRNAs in embryonic and pressure overloaded hearts (Fig.  3D, Venn diagram) resembles the partial recapitulation of embryonic heart mRNA (Fig. 3F, Venn diagram) and microRNA expression signatures in diseased adult hearts (18, (20) (21) (22) . The minimal overlap of regulated lncRNAs in fetal and pressure overloaded (TAC) hearts suggests a limited role for lncRNAs in genetic reprogramming of hemodynamically stressed adult hearts.
Coregulated cis lncRNA-mRNA Pairs in the Embryonic-to-Adult Heart Transition. Genomic location is critical to the actions of lncRNAs that regulate neighboring genes in cis and can help uncover functional lncRNA-mRNA relationships (23) . To gain insight into the consequences of lncRNAs on cardiac gene expression, we mapped regulated cardiac lncRNAs to the mouse genome, identified coding mRNAs within 10 kb, and assessed their mutual dynamism as a function of cardiac condition.
We identified 33 lncRNA-mRNA cis pairs in which both the lncRNA and mRNA were regulated (FDR < 0.02; >50% increase or decrease) in embryonic hearts (Fig. 4A) . Importantly, none of these lncRNAs were significantly regulated in pressure overloaded adult hearts. Twenty-two lncRNA-mRNA pairs (excluding lncRNAs and mRNAs at overlapping genomic loci) exhibited concordant regulation between embryonic and adult hearts (Fig. S5) (24) , whereas 11 lncRNA-mRNA pairs showed nonconcordant regulation (Fig. 4A, asterisks) , suggesting a suppressive function of these lncRNAs (24) .
The lncRNAs in reciprocally regulated pairs comprised members of natural antisense transcript, intronic, and intergenic families (Fig. S6) , including Kcnq1ot1/n413804 that is encoded on the opposite strand of, and has been validated as regulating, the Kcnq1 gene in embryonic hearts (Fig. 4B) (25) . As the remaining pairs represented novel relationships, we used gapmeR (antisensemediated) knockdown of lncRNAs in the C2C12 mouse skeletal myoblast line to validate the dependency of mRNA expression on cis lncRNA levels for two: lncRNA n411949/mRNA Mccc1 and lncRNA n413445/mRNA Relb. Although C2C12 cells are often used in differentiation studies, we performed these experiments in nondifferentiating C2C12 cells to take advantage of musclelike background gene expression in cells that could nonetheless be readily transfected. lncRNA n411949 is an example of an antisense lncRNA overlapping protein coding exons, whereas lncRNA n413445 represents an intronic lncRNA. Their cognate mRNAs, Mccc1 and Relb, were increased in response to anti-lncRNA gapmeR transfection (compared with a negative control oligonucleotide transfection), using gapmeRs targeted toward two different positions on each lncRNA (Fig. 5) . Thus, these data confirm these lncRNA-mRNA regulatory relationships.
lncRNA Involvement in Regulated Expression of Genes Important for Cardiac Development. Two-thirds of the lncRNA-associated mRNAs in the 33 coregulated lncRNA-mRNA pairs could be assigned to functional classes relating to tissue growth and development, including DNA replication and transcription, mRNA processing and translation, and protein synthesis and transport (Table S1 ). Network analysis of these lncRNA-modulated mRNAs uncovered involvement in major cardiac development and metabolic pathways and also pointed to central roles for the transcription factors CREB1 and NFκB (of which RelB is a critical subunit). Other regulated mRNAs in these pathways are apparently modulated through conventional transcriptional mechanisms rather than by dynamically expressed cardiac lncRNAs (Fig. 6) .
Discussion
There is an explosion of interest in regulatory noncoding RNAs, especially lncRNAs. We and others have been frustrated by the absence of basic general information on lncRNAs in the fully differentiated mammalian heart and especially by the lack of rigorously annotated, quantitative expression data in adult mouse models (26) (27) (28) . Here, we identified hundreds of cardiac-expressed and dozens of cardiac-enriched (not cardiac-specific) lncRNAs, providing a foundation on which we can advance our understanding of lncRNA biology in the heart. Our studies delineate greater than 100 dynamically regulated lncRNAs in embryonic hearts but relatively few in reactive adult cardiac hypertrophy. In fact, lncRNAs regulated in hypertrophy thus exhibit only limited recapitulation of fetal lncRNA expression. This observation is consistent with the notion, supported by functional classification and network analysis of regulated lncRNAs and their co-or reciprocally regulated mRNA partners, that a dominant function of cardiac lncRNAs is epigenetic modulation of developmental gene expression.
lncRNAs use diverse molecular regulatory mechanisms to regulate their target genes, including acting as antisense transcripts that directly bind mRNA or acting as chaperones that recruit macromolecular protein complexes to specific sequencespecified locations in the genome (29) . A common theme for the latter mechanism is chromatin remodeling that evokes long-term changes in transcriptional activity (27) . Such remodeling represents chronic, rather than acute, regulation of gene expression, consistent with our observation that dynamic regulation of lncRNAs and their partner mRNAs is more evident during embryonic heart development than in the adult cardiac stress response. The abundance of lncRNAs that are an order of magnitude less than that of their validated and putative partner mRNAs is also consistent with the notion that at least some lncRNAs act in a nonlinear manner via recruitment of chromatin remodeling protein complexes to regulate mRNA transcription.
Little is known about overall lncRNA function in the heart, but three cardiac-expressed lncRNAs have been studied in detail. Kcnq1ot1 (n413804) mediates transcriptional silencing through histone methylation of the overlapping Kcnq1/Kv7.1 potassium channel gene and other genes at the same genomic locus (30) (31) (32) . In our studies, Kcnq1ot1 is expressed at high levels in embryonic hearts, but decreases by fivefold in adult hearts. Its mRNA partner, Kcnq1, encodes the Kv7.1 slow delayed rectifying potassium channel that is essential for normal cardiomyocyte repolarization that terminates the action potential and cardiomyocyte contraction. Coinciding with decreased Kcnq1ot1 expression, levels of Kcnq1 mRNA increase, consistent with the need for enhanced pump function during the transition between developing embryonic and fully functioning adult hearts.
Fendrr is expressed specifically in embryonic lateral mesoderm where it regulates heart development, likely by modifying the chromatin signatures of genes encoding transcription factors that direct cardiomyocyte differentiation (4). We did not detect Fendrr in hearts of ∼E14.5 mouse embryos or of adult mice, consistent with a transient role in the specification and differentiation of mesoderm to cardiomyocytes, which is largely complete and supplanted by cardiomyocyte proliferation at E14.5.
Braveheart (Bvht) is another cardiac-expressed lncRNA that epigenetically regulates cardiomyocyte differentiation (3). In our studies, Braveheart (annotated as n267831) was cardiac-enriched approximately threefold compared with other tissues, but expressed in the heart at similar levels in E14.5 embryos and adults; Braveheart is also not regulated late after hemodynamic stress. Constitutive cardiac expression of Braveheart suggests that it may have "housekeeping" roles in adult hearts in addition to its canonical role upstream of MesP1 to stimulate and maintain cardiomyocyte fate.
Our studies identified possible functional interactions between 10 further lncRNAs and neighboring mRNAs that were reciprocally regulated between embryonic and adult hearts; we validated two of these using lncRNA knockdown in mouse C2C12 skeletal myoblasts. The importance of one of these lncRNAregulated mRNAs, Relb, was captured in our network analysis pointing to a central role for NFκB in modulating altered gene expression during cardiac growth and transition to the adult heart. lncRNA n413445 expression is high in the embryonic heart but is quite low in adult hearts. As its levels decline, levels of Relb mRNA increase, providing increased expression of the RelB transcription factor that is an essential component of the NFκB pathway (33) . An increase of the lncRNA n411949-regulated mRNA Mccc1 during fetal cardiac growth may be of key importance for sensing free leucine levels and thus the availability of branched-chain amino acids for anabolic signaling in muscle (34, 35) . Mccc1 is one among several enzymes that metabolize leucine; interestingly, the mRNA levels of at least three others in the same catabolic pathway (Ivd, Mccc2, and Auh) increase dramatically during the transition to the adult heart (Dataset S7).
Study Limitations. Our studies of embryonic hearts were designed to be compared with pressure overloaded adult hearts and therefore focused on a relatively late time during development when cardiomyocyte growth was dominant and mesodermal specification and differentiation were largely complete. A detailed time course of lncRNA expression in earlier stage embryos will be required to understand the role of lncRNA regulation in cardiomyocyte differentiation. Likewise, studies in postnatal hearts during the transition Fig. 6 . Signaling networks of mRNAs involved in lncRNA-mRNA relationships. MetaCore analysis of functional networks involving regulated cardiac mRNAs linked to regulated cardiac lncRNAs. Green arrows, up-regulation; red arrows, down-regulation; gray lines, context-dependent interaction. Blue circles are mRNAs directly linked to regulated lncRNAs, green circles are mRNAs also regulated, but not connected to lncRNAs described in our study. Note central nodes for NFκB and CREB1.
